These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant. Li Z, Wang S, Zhang H, Xi L, Zhang J, Zhang X, Zhou Q, Yi J, Li M, Zhang W, Zhang J. Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131 [Abstract] [Full Text] [Related]
24. Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model. Uslu A, Erganis O. Mol Immunol; 2021 May; 133():44-52. PubMed ID: 33631554 [Abstract] [Full Text] [Related]
38. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice. Golshani M, Rafati S, Dashti A, Gholami E, Siadat SD, Oloomi M, Jafari A, Bouzari S. Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468 [Abstract] [Full Text] [Related]